“…6 Cytarabine, cladribine and etoposide have been tried in addition to conventional modalities like methrotrexate, azathioprine and thalidomide. 6 Also, radiotherapy has a role in selective cases of adults, as opposed to pediatric cases. 6 More recently, vemurafinib, a tyrosine-kinase inhibitor, has been used albeit off-label, in a BRAF V600E positive, multi-refractory disease.…”